Cyclic amine monoamides for extracting uranium(VI) and plutonium(IV) and separating them without reducing plutonium(IV)
Cyclic amine monoamides facilitate the efficient and safe separation of uranium and plutonium from spent nuclear fuel without plutonium reduction, addressing the limitations of the PUREX process and enhancing the safety and efficiency of nuclear fuel processing.
Patent Information
- Application Number
- JP2024523755
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2021-10-21
- Filing Date
- 2022-10-14
- Publication Date
- 2024-11-13
AI Technical Summary
The PUREX process for extracting uranium and plutonium from spent nuclear fuel requires reduction of plutonium(IV) to plutonium(III), leading to safety concerns due to the generation of unstable reactive species and inefficiencies in separation, which is not suitable for future nuclear fuel processing plants.
The use of cyclic amine monoamides, such as N-(2-heptylpyrrolidinyl)-(2-ethyl)hexanamide, for co-extracting uranium(VI) and plutonium(IV) without reducing plutonium(IV), allowing for complete or partial separation in a single cycle by liquid-liquid extraction, followed by selective back-extraction and re-extraction steps to achieve high purity.
This method enables efficient, safe, and efficient separation of uranium and plutonium without plutonium reduction, reducing the risk of reoxidation and hazardous waste, and is suitable for processing fuels with higher plutonium content, with improved decontamination and reduced solvent use.
Smart Images

Figure 2024541881000001_ABST
Abstract
Description
[Technical field]
[0001] The present invention is directed to the field of spent nuclear fuel processing.
[0002] More particularly, the present invention is directed to the use of cyclic amine monoamides for the extraction of uranium (VI) and / or plutonium (IV) from acidic aqueous solutions, in particular aqueous solutions produced by dissolving spent nuclear fuel in nitric acid.
[0003] The present invention is also directed to the use of these cyclic amine monoamides for the complete or partial separation of uranium (VI) from plutonium (IV) from acidic aqueous solutions, in particular from aqueous solutions resulting from the dissolution of spent nuclear fuel in nitric acid.
[0004] The present invention also relates to a method for treating an aqueous solution resulting from the dissolution of spent nuclear fuel in nitric acid, making it possible to extract, separate and decontaminate in a single cycle the uranium(VI) and plutonium(IV) present in this solution, without resorting to any operation that reduces plutonium(IV), in which one of these cyclic amine monoamides or a mixture of these is used as an extractant.
[0005] The present invention is further directed to cyclic amine monoamides that are useful in the above-mentioned uses and methods.
[0006] The invention finds application in the processing of spent nuclear fuel based on uranium (particularly uranium oxide, known as UOX fuel), or based on uranium and plutonium (particularly mixed oxide of uranium and plutonium, known as MOX fuel). [Background technology]
[0007] The PUREX process is used in all spent nuclear fuel processing plants around the world (La Hague in France, Rokkasho in Japan, Sellafield in the UK, etc.) and uses tri-n-butyl phosphate (or TBP) as the extractant to recover these fuels by liquid-liquid extraction from the aqueous solution produced by dissolving uranium(VI) and plutonium(IV) in nitric acid.
[0008] In this method, TBP is used as a 30% (v / v) solution in an aliphatic diluent such as hydrogenated tetrapropylene (or TPH) type. This organic solution is commonly called the "solvent" in the field under consideration.
[0009] Uranium and plutonium are recovered by the PUREX process in several cycles: - a first cycle for purifying uranium(VI) and plutonium(IV) (called "1CUPu"), which aims to decontaminate these elements with respect to minor actinides (neptunium, americium and curium) and fission and activation products, from this first cycle onwards, distributing uranium(VI) and plutonium(IV) into two aqueous streams; - a second cycle for the purification of uranium(VI) (called "2CU"), which aims to intensify the decontamination of this element to achieve the specifications stipulated by the ASTM standard for uranium as the final product; - the second cycle, and in some plants the third cycle (respectively called "2CPu" and "3CPu"), for the purification of plutonium(IV), which aims to intensify the decontamination of this element to achieve the specifications set by the ASTM standards for plutonium as the final product, concentrating it before its conversion into the oxide PuO2.
[0010] The performance of the PUREX process has been satisfactory and feedback from plants that have implemented it since commissioning has been positive.
[0011] However, the use of TBP has limitations in that this extractant is at odds with the potential to achieve the goals of simplicity, compactness, and improved safety set for future spent nuclear fuel processing plants.
[0012] The main limitation is that partitioning uranium and plutonium into two aqueous streams requires the reduction of plutonium(IV) to plutonium(III) because TBP has an insufficient partition factor between uranium(VI) and plutonium(IV) regardless of the acidity of the aqueous solution used for partitioning. As a result, the use of TBP requires the use of large amounts of reducing agents and anti-nitrous agents, which are restrictive from a safety point of view due to the generation of unstable reactive species upon decomposition.
[0013] Several studies have therefore been carried out to provide an extractant capable of quantitatively co-extracting uranium and plutonium from the aqueous solution resulting from the dissolution of spent nuclear fuel in nitric acid, and then ensuring a complete or partial separation of these two elements without the need for the reduction of plutonium(IV) to plutonium(III).
[0014] This has led to the following proposed uses: - symmetric N,N-dialkylamides, such as N,N-di(2-ethylhexyl)-3,3-dimethylbutanamide (or DEHDMBA), according to WO 2017 / 017207 (hereinafter reference [1]); asymmetric N,N-dialkylamides, e.g. * N-Methyl-N-octyl-2-ethylhexanamide (or MOEHA) or N-decyl-N-methyl-2-ethylhexanamide (or MDEHA) in WO 2017 / 017193 (hereafter, reference [2]); * N-Methyl-N-nonyl-2-methylhexanamide (or MNMHA) or N-Methyl-N-hexyl-2-propylheptanamide (or MHPHepA) in WO 2018 / 138441 (hereafter, reference [3]), and - tetraalkylated carbamides, such as N,N,N',N'-tetra-n-butylurea (or TBU) or trialkylated carbamides, such as N,N,N'-tri-n-octylurea (or TrOU), in WO 2019 / 002788 (hereinafter reference [4]).
[0015] All these extractants, especially the asymmetric N,N-dialkylamides of references [2] and [3], were found to exhibit very interesting performances.
[0016] Furthermore, within the scope of a study published in 1960 in J. Phys. Chem, 64, 12, pp. 1863-1866 (hereafter Ref. [5]), with the aim of evaluating the ability of a number of N,N-disubstituted amides to extract uranium(VI) and plutonium(IV) from a strongly acidic aqueous phase of nitric acid (3 mol / L and 6 mol / L), T. H. Siddall studied the ability of two cyclic amine monoamides, namely N-hexanoylpiperidine and N-2-ethylhexanoylpiperidine, at a concentration of 0.5 mol / L in toluene.
[0017] Also reported by H. Jing-Tian et al. (Journal of Radioanalytical and Nuclear Chemistry 1999, 241, pp. 215-217, hereafter Ref. [6]) are data on the extraction of uranium(VI) by a cyclic amine monoamide, in this case N-octanoylpyrrolidine, at a concentration of 0.3 mol / L in toluene.
[0018] Reference [5] shows that, although structurally very similar, the two piperidine monoamides give opposing extraction results under the same operating conditions, regardless of whether the acidity of the nitric acid is 3 mol / L or 6 mol / L, because at these two acidities, N-hexanoylpiperidine extracts plutonium(IV) better than uranium(VI), whereas N-2-ethylhexanoylpiperidine extracts uranium(VI) better than plutonium(IV).
[0019] Reference [6] reported that when used at a concentration of 0.3 mol / L in toluene, N-octanoylpyrrolidine very weakly extracted uranium(VI) from 3 mol / L aqueous nitric acid, with a distribution coefficient D U is stated to be less than 1 at 25°C.
[0020] Furthermore, in view of the above, the data reported in references [5] and [6] do not specifically encourage the use of cyclic amine monoamides for the quantitative co-extraction of uranium(VI) and plutonium(IV) from strongly acidic aqueous solutions of nitric acid, nor do they give any indication as to the possibility of using compounds of this type to separate uranium(VI) from plutonium(IV) after they have been co-extracted from such solutions, without recourse to the reduction of plutonium(IV) to plutonium(III). [Prior art documents] [Patent documents]
[0021] [Patent Document 1] International Publication No. 2017 / 017207 [Patent Document 2] International Publication No. 2017 / 017193 [Patent Document 3] International Publication No. 2018 / 138441 [Patent Document 4] International Publication No. 2019 / 002788 [Non-patent literature]
[0022] [Non-Patent Document 1] 1960, J. Phys. Chem, 64, 12, pp. 1863~1866 [Non-Patent Document 2] H. Jing-Tian et al., Journal of Radioanalytical and Nuclear Chemistry, 1999, 241, 215-217 Summary of the Invention [Means for solving the problem]
[0023] Within the scope of the above studies, the inventors have observed that monoamides having an azetidine, pyrrolidine, or piperidine ring substituted with one or more alkyl or alkoxy groups have the following extraction properties: - in the presence of a strongly acidic aqueous phase of the type found in the aqueous solutions produced by dissolving spent nuclear fuel in nitric acid, these monoamides provide distribution coefficients for uranium(VI) and plutonium(IV) suitable for quantitative co-extraction of these two elements from this aqueous phase; and In the presence of a moderately acidic aqueous phase, these monoamides provide a U(VI) / Pu(IV) separation factor suitable for separating uranium(VI) from plutonium(IV), without the need for reducing plutonium(IV) to plutonium(III), this separation being complete or partial, as desired.
[0024] The present invention is based on these experimental findings.
[0025] Therefore, firstly, one object of the present invention is to provide a method for extracting uranium (VI) and / or plutonium (IV) from an acidic aqueous solution having a pH less than 0, comprising the steps of: [ka] (In the formula, n=1, 2, or 3; R 1 is a linear or branched alkyl group containing 4 to 12 carbon atoms, and R 2 is a straight or branched chain alkyl or alkoxy group, the chain of which may optionally be interrupted one or more times by oxygen atoms, the total number of carbon atoms and, where applicable, oxygen atoms being between 3 and 10. The use of a monoamide or a mixture of monoamides.
[0026] In the above and below, the phrases "to", "in the range of" and "between" are meant to be synonymous and include the limits therein.
[0027] Furthermore, - "linear or branched alkyl group containing from 4 to 12 carbon atoms" means any alkyl group, the chain of which may or may not contain one or more identical or different branches, the number of carbon atoms of which is equal to 4, 5, 6, 7, 8, 9, 10, 11 or 12; - "a straight or branched chain alkyl or alkoxy group, the chain of which may or may not contain one or more identical or different branches and one or more insertions of oxygen atoms between two carbon atoms, and the total number of carbon and oxygen atoms (if one or more oxygen atoms are present) is equal to 3, 4, 5, 6, 7, 8, 9, or 10" means any alkyl or -O-alkyl group, the chain of which may or may not contain one or more identical or different branches and one or more insertions of oxygen atoms between two carbon atoms, and the total number of carbon and oxygen atoms (if one or more oxygen atoms are present) is equal to 3, 4, 5, 6, 7, 8, 9, or 10.
[0028] According to the invention, uranium(VI) and / or plutonium(IV) is preferably extracted from the acidic aqueous solution by liquid-liquid extraction, i.e. by contacting the aqueous solution with an organic solution comprising a monoamide or a mixture of monoamides in an organic diluent and then separating the aqueous and organic solutions from each other.
[0029] In this case, the organic solution preferably contains from 1 mol / L to 2 mol / L, even more preferably from 1 mol / L to 1.3 mol / L of the monoamide or mixture of monoamides, preferentially at a concentration of 1.2 mol / L.
[0030] The acidic aqueous solution is preferably an aqueous solution produced by dissolving spent nuclear fuel in nitric acid, ie, an aqueous solution typically containing 3 mol / L to 6 mol / L of nitric acid.
[0031] In the above and below, "organic diluent" means any non-polar hydrocarbon or mixture of non-polar aliphatic and / or aromatic hydrocarbons, the use of which is provided to dissolve the lipophilic extractant. Examples of such diluents include, inter alia, n-dodecane, hydrogenated tetrapropylene (TPH), kerosene, and isoparaffinic diluents, such as those sold under the references Isane® IP-185 and Isane® IP-175 by the company TotalEnergies.
[0032] In addition to being able to quantitatively extract uranium(VI) and plutonium(IV) from an acidic aqueous solution having a pH below 0, the monoamides of formula (I) above have been shown to subsequently make it possible to separate the uranium and plutonium thus co-extracted from one another, without the need to reduce plutonium(IV) to plutonium(III), where this separation can be either: - complete separation of uranium(VI) and plutonium(IV), i.e., two aqueous solutions are obtained, one containing plutonium(IV) without uranium(VI), the other containing uranium(VI) without plutonium(IV); - or partial separation of uranium(VI) and plutonium(IV), i.e. here, two aqueous solutions are obtained, one containing a mixture of plutonium(IV) and uranium(VI), the other containing uranium(VI) without plutonium(IV).
[0033] Therefore, another object of the present invention is the use of a monoamide of formula (I) or a mixture of monoamides for the complete or partial separation of uranium (VI) from plutonium (IV) from an acidic aqueous solution having a pH below 0, comprising the following steps: a) co-extraction of uranium(VI) and plutonium(IV) from said aqueous solution, comprising contacting said aqueous solution at least once with an organic solution S1 comprising the monoamide of formula (I) or a mixture of monoamides in an organic diluent, followed by separation of the aqueous and organic solutions from each other; b) stripping plutonium in the +IV oxidation state and a portion of uranium(VI) from the organic solution obtained from step a), comprising contacting the organic solution at least once with an aqueous acid solution having a pH greater than 0, better still greater than 0.3, followed by separating the organic and aqueous solutions from each other; and c) a re-extraction step of all or part of the uranium(VI) moiety present in the aqueous solution obtained from step b), which comprises contacting the aqueous solution at least once with an organic solution S2 comprising a monoamide or a mixture of monoamides in an organic diluent, followed by separation of the organic and aqueous solutions from each other; whereby an aqueous solution containing plutonium (IV) without uranium (VI) or a mixture of plutonium (IV) and uranium (VI) is obtained, and an organic solution containing uranium (VI) without plutonium (IV). It is use.
[0034] The organic solutions S1 and S2 preferably contain a monoamide or a mixture of monoamides at a concentration of 1 mol / L to 2 mol / L, better still 1 mol / L to 1.3 mol / L, most preferably at a concentration of 1.2 mol / L.
[0035] The aqueous solution having a pH of less than 0 is preferably an aqueous solution produced by dissolving spent nuclear fuel in nitric acid, i.e., an aqueous solution typically containing 3 mol / L to 6 mol / L of nitric acid, and in this case, the acidic aqueous solution having a pH of more than 0 is preferably a solution containing 0.1 mol / L to 0.5 mol / L of nitric acid.
[0036] The uranium present in the organic solution resulting from step c) can then be extracted from this phase by contacting the organic solution with an acidic aqueous solution having a pH of at least 1.3, for example a solution containing at most 0.05 mol / L nitric acid, and then separating the organic and aqueous solutions from each other.
[0037] In addition to possessing the above mentioned properties, the monoamides of formula (I) above have been shown to provide organic phases with dynamic viscosities and uranium(VI) loading capacities perfectly suited for their use in processes for treating spent nuclear fuel.
[0038] This combination of properties has made it possible to develop a process for treating aqueous nitric solutions resulting from the dissolution of spent nuclear fuel, which is as effective as the PUREX process in recovering and decontaminating the uranium and plutonium present in such solutions, but which does not involve any plutonium reduction stripping operation and which involves only a single treatment cycle.
[0039] Another object of the present invention is therefore a method for treating in a cycle an aqueous solution resulting from the dissolution of spent nuclear fuel in nitric acid, the aqueous solution containing fission and activation products including uranium (VI), plutonium (IV), americium (III), curium (III), and ruthenium and technetium, the cycle comprising the following steps: a) co-extraction of uranium(VI) and plutonium(IV) from said aqueous solution, comprising contacting the aqueous solution at least once in an extractor with an organic solution S1 comprising the monoamide of formula (I) or a mixture of monoamides in an organic diluent, followed by separation of the aqueous and organic solutions from each other; b) decontaminating the organic solution resulting from step a) with respect to americium(III), curium(III) and fission and activation products, comprising contacting the organic solution at least once in an extractor with an aqueous solution containing 0.5 mol / L to 6 mol / L of nitric acid, followed by separating the aqueous and organic solutions from each other; c) partitioning the uranium(VI) and plutonium(IV) present in the organic solution resulting from step b) between an aqueous solution containing plutonium(IV) but not uranium(VI) or a mixture of plutonium(IV) and uranium(VI) and an organic solution containing uranium(VI) but not plutonium(IV), comprising the following steps: c1) A step of back-extracting the plutonium in +IV oxidation state and the uranium(VI) fraction from the organic solution resulting from step b), which comprises contacting the organic solution at least once in an extractor with an aqueous solution containing 0.1 mol / L to 0.5 mol / L of nitric acid, followed by separating the organic and aqueous solutions from each other; c2) a re-extraction step of all or part of the uranium(VI) fraction present in the aqueous solution resulting from step c1), which comprises contacting said aqueous solution at least once in an extractor with an organic solution S2 comprising a monoamide or a mixture of monoamides in an organic diluent, followed by separation of the aqueous and organic solutions from each other, a dispensing step comprising: d) decontaminating the organic solution resulting from step c1) with respect to technetium, comprising the steps of: d1) back-extraction of technetium in the +IV oxidation state from the organic solution resulting from step c1), comprising contacting the organic solution at least once in an extractor with an aqueous solution containing 0.1 mol / L to 3 mol / L of nitric acid and at least one reducing agent capable of reducing technetium from the +VII oxidation state to the +IV oxidation state, followed by separating the organic and aqueous solutions from each other; d2) re-extracting the uranium(VI) fraction present in the aqueous solution resulting from step d1), comprising contacting said aqueous solution at least once in an extractor with an organic solution S3 comprising a monoamide or a mixture of monoamides in an organic diluent, followed by separation of the aqueous and organic solutions from each other, a step of decontaminating comprising: e) back-extracting uranium(VI) from the organic solution resulting from step d1), comprising contacting the organic solution at least once in an extractor with an aqueous solution containing at most 0.05 mol / L nitric acid, followed by separating the organic and aqueous solutions from each other; and f) optionally regenerating the organic solution from step e); whereby first and second aqueous solutions decontaminated with respect to americium (III), curium (III) and fission and activation products are obtained, the first aqueous solution containing plutonium (IV) without uranium (VI) or a mixture of plutonium (IV) and uranium (VI), and the second aqueous solution containing uranium (VI) without plutonium (IV), This is the method.
[0040] According to the invention, the organic solutions S1, S2 and S3 preferably contain a monoamide or a mixture of monoamides in a concentration of 1 mol / L to 2 mol / L, better still 1 mol / L to 1.3 mol / L, most preferably 1.2 mol / L.
[0041] As indicated above, the aqueous solution used in step b) can contain 0.5 mol / L to 6 mol / L of nitric acid. However, this aqueous solution preferably contains 4 mol / L to 6 mol / L of nitric acid so as to facilitate the stripping of ruthenium and technetium from the organic solution resulting from step a). In this case, step b) advantageously also comprises deacidifying the organic solution, which comprises contacting the organic solution at least once with an aqueous solution containing 0.1 mol / L to 1 mol / L, better still 0.5 mol / L, of nitric acid, followed by separating the organic and aqueous solutions from each other.
[0042] According to the invention, the contacting of the organic solution with the aqueous solution in the extractor in which step c1) is carried out comprises circulating these solutions with an O / A flow ratio advantageously greater than 1, preferably greater than or equal to 3 and even more advantageously greater than or equal to 5, so as to obtain a concentrated stripping of plutonium (i.e. a stripping of plutonium resulting in an aqueous solution in which the concentration of plutonium is higher than the concentration of plutonium in the organic solution to be stripped).
[0043] The reducing agent(s) present in the aqueous solution used in step d1) are preferably selected from uranyl nitrate (also known as "U(IV)"), hydrazinium nitrate (also known as "hydrazine nitrate"), hydroxylammonium nitrate (also known as hydroxylamine nitrate), acetaldoxime, hydroxyiminoalkanoic acids (e.g. 6-hydroxyiminohexanoic acid) and mixtures thereof, such as mixtures of uranyl nitrate and hydrazinium nitrate, mixtures of uranyl nitrate and hydroxylammonium nitrate or mixtures of uranyl nitrate and acetaldoxime, preferentially mixtures of uranyl nitrate and hydrazinium nitrate or mixtures of uranyl nitrate and hydroxylammonium nitrate, which are preferably used in concentrations ranging from 0.1 mol / L to 0.3 mol / L, typically 0.2 mol / L.
[0044] Furthermore, step d1) can be carried out at room temperature, but is preferably carried out at a temperature ranging from 30° C. to 40° C., better still at 32° C., so as to limit as much as possible the phenomenon of reoxidation of this element in the aqueous phase, while facilitating the rate of back-extraction of technetium. The extractor in which step d1) is carried out is therefore preferably heated to a temperature between 30° C. and 40° C.
[0045] According to the invention, step d2) preferably additionally comprises acidifying the aqueous solution resulting from step d1), which comprises adding nitric acid to the extractor in which step d2) is carried out in order to bring the concentration of nitric acid in the aqueous solution to a value at least equal to 2.5 mol / L.
[0046] Step e) may be carried out at room temperature, but is preferably carried out at a temperature between 40° C. and 50° C., also to facilitate stripping of the uranium. The extractor in which step e) is carried out is therefore preferably heated to a temperature between 40° C. and 50° C.
[0047] Whatever the temperature at which step e) is carried out, the contacting of the organic and aqueous solutions in the extractor in which this step is carried out comprises circulating these solutions at an O / A flow ratio greater than 1 so as to obtain concentrated stripping of uranium (i.e. stripping of uranium resulting in an aqueous solution in which the concentration of uranium in the aqueous solution is higher than the concentration of uranium in the organic solution being stripped).
[0048] Preferably, the method comprises a step f) of regenerating the organic solution from step e), which preferably comprises washing the organic solution with at least an aqueous basic solution, followed by washing the organic solution with at least an aqueous nitric acid solution.
[0049] In this case, the organic solution thus regenerated is then advantageously divided into a first and a second fraction, the first fraction forming the organic solution S1 used in step a) and the second fraction forming the organic solution S2 used in step c2).
[0050] The method described in this invention has several advantages. Indeed, - uranium stripping is easier to implement than the PUREX process, since it can be carried out both at room temperature and under heating, using O / A flow ratios greater than 1, which allows uranium to be stripped in a concentrated form, which is not possible with the PUREX process; - plutonium stripping is also easier to implement than the PUREX process, since it does not involve any plutonium reduction reactions and therefore eliminates any risk of plutonium reoxidation, and can be carried out in a more highly enriched manner than the latter; these advantages are all the more important, since future spent fuel processing plants will have to process fuels that are richer in plutonium than the fuels currently being processed (such as MOX fuel from light water reactors or fast neutron reactors); - The degradation products of the monoamides (by hydrolysis and radiolysis) are less problematic than those of TBP because they are soluble in water and do not form complexes that could retain plutonium; the solubility of the monoamide in the aqueous phase is typically 100 to 200 times lower than that of TBP, which makes it possible to expect that the number of washings with organic diluents of the aqueous solutions obtained by the process of the invention will be unnecessary or at least reduced with respect to those provided by the PUREX process; - The monoamides and their decomposition products, unlike TBP and its decomposition products, contain only carbon, hydrogen, oxygen and nitrogen atoms and can therefore be completely incinerated and therefore do not produce any hazardous secondary wastes.
[0051] As previously indicated, in formula (I) above, n can be equal to 1, 2, or 3.
[0052] In this case, the monoamide of formula (I) may have one of the following specific formulae (Ia), (Ib) or (Ic): [ka]
[0053] According to the invention, n is preferably equal to 2 or 3 and therefore the monoamide of formula (I) preferably has one of the particular formulae (Ib) and (Ic).
[0054] Furthermore, R 1 is advantageously a straight or branched alkyl group containing 6 to 10 carbon atoms, and better still a branched alkyl group, such as 1-methylpentyl, 1-methylhexyl, 1-methylheptyl, 1-methyloctyl, 1-methylnonyl, 1-ethylpentyl, 1-ethylhexyl, 1-ethylheptyl, 1-ethyloctyl, 1-propylbutyl, 1-propylpentyl, 1-propylhexyl, 1-propylheptyl, 2-ethylhexyl, 2-ethylheptyl, 2-ethyloctyl groups, etc. Of these, most preferably it is the 1-ethylpentyl or 1-propylbutyl group.
[0055] R 2 is advantageously a linear or branched alkyl group containing from 4 to 10 carbon atoms, and better still a linear alkyl group, i.e. the n-butyl, n-pentyl, n-hexyl, n-heptyl, n-octyl, n-nonyl or n-decyl group. Of these, most preferably it is the n-hexyl, n-heptyl or n-octyl group.
[0056] Monoamides meeting these priorities are, inter alia: N-(2-heptylpyrrolidinyl)-(2-ethyl)hexanamide (hereinafter referred to as EHPyr2), which has the specific formula (Ib) 1 represents a 1-ethylpentyl group, while R 2 represents an n-heptyl group carried by the carbon atom located at position 2 of the pyrrolidine ring; - N-(2-hexylpiperidinyl)-(2-ethyl)hexanamide (hereinafter referred to as EHPip2), which has the specific formula (Ic) 1represents a 1-ethylpentyl group, while R 2 represents an n-hexyl group carried by the carbon atom located in the 2-position of the piperidine ring; - N-(3-hexylpiperidinyl)-(2-ethyl)hexanamide (hereinafter referred to as EHPip3), which has the specific formula (Ic) 1 represents a 1-ethylpentyl group, while R 2 represents an n-hexyl group carried by the carbon atom located in the 3-position of the piperidine ring; - N-(4-hexylpiperidinyl)-(2-ethyl)hexanamide (hereinafter referred to as EHPip4), which has the specific formula (Ic) 1 represents a 1-ethylpentyl group, while R 2 represents an n-hexyl group carried by the carbon atom located in the 4-position of the piperidine ring; and N-(3-hexylpiperidinyl)-(2-propyl)pentanamide (hereinafter referred to as PPPip3), which has the specific formula (Ic) in which R 1 represents a 1-propylbutyl group, while R 2 represents an n-hexyl group carried by the carbon atom located in the 3-position of the piperidine ring.
[0057] Of these, the monoamide EHPyr2 is most preferably used because, in addition to being very effective in co-extracting uranium(VI) and plutonium(IV) from a strongly acidic aqueous phase, for example an aqueous phase containing 3 mol / L to 6 mol / L of nitric acid, it has a particularly high selectivity for uranium(VI) over plutonium(IV) in the presence of a moderately acidic aqueous phase, for example an aqueous phase containing 0.1 mol / L to 0.5 mol / L of nitric acid.
[0058] Some of the monoamides of formula (I) are known from the state of the art, whereas others, to the best of the inventors' knowledge, have not been described in the literature.
[0059] The present invention further relates to these new monoamides, which are: - N-(2-heptylpyrrolidinyl)-(2-ethyl)hexanamide, - N-(2-hexylpiperidinyl)-(2-ethyl)hexanamide, - N-(3-hexylpiperidinyl)-(2-ethyl)hexanamide, N-(4-hexylpiperidinyl)-(2-ethyl)hexanamide, and - N-(3-hexylpiperidinyl)-(2-propyl)pentanamide It is.
[0060] Further features and advantages of the present invention will become apparent from the following description.
[0061] It should be understood, however, that this further description is given merely as an illustration of the scope of the present invention and should not be construed as limiting this scope in any way. [Brief description of the drawings]
[0062] [Figure 1] FIG. 1 shows a schematic diagram of a method for treating an aqueous solution resulting from dissolving spent nuclear fuel in nitric acid according to the invention. In this diagram, rectangles 1 to 7 represent multi-stage extractors, such as those conventionally used for the treatment of spent nuclear fuel (mixer-settler, pulse column or centrifugal extractor). The organic phase is represented by a solid line, while the aqueous phase is represented by a dotted line. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0063] I- Synthesis of monoamides of formula (I) : The monoamides of formula (I) can be synthesised by two different procedures, referred to below as A and B, respectively.
[0064] Step A : This is the formula: R 1 -COOH(where R 1 has the same meaning as in formula (I) with a carboxylic acid of the formula: [ka] (Wherein, n and R 2 has the same meaning as in formula (I) It is based on the reaction of with cyclic amines.
[0065] This reaction can be carried out, for example, as follows: A solution of 1-hydroxybenzotriazole monohydrate (or HOBt - 1.20 eq.) and N,N-dicyclohexylcarbodiimide (or DCC - 1.20 eq.) in 2-methyltetrahydrofuran (0.2 mol / L) is stirred at room temperature for 10 minutes until complete dissolution. The carboxylic acid (1.00 eq.) is then added to the mixture. The resulting solution is stirred for 10 minutes, then a solution of a cyclic amine (1.00 eq.) (optionally in the form of a salt) in 2-methyltetrahydrofuran is added. The resulting suspension is stirred overnight at room temperature and then filtered through Celite™. The filtrate is washed twice with saturated sodium bicarbonate solution and once with saturated sodium chloride solution. The solution is finally dried over magnesium sulfate, filtered and then concentrated under reduced pressure.
[0066] Step B : This is the formula: R 1 -C(O)X acid halides, where X represents a halogen atom, for example a chlorine atom, and R 1 has the same meaning as in formula (I)) with a cyclic amine of the formula shown above.
[0067] This reaction can be carried out as follows: triethylamine (1.50-4.00 eq.) is added to a solution of the cyclic amine (1.00 eq.) (optionally in the form of a salt) in dichloromethane (or DCM). The resulting solution is stirred at room temperature for 10 minutes and then the acid halide (1.50 eq.) is added. After stirring at room temperature for 2 hours, water is added to the reaction medium. The aqueous phase is then extracted three times with dichloromethane. The organic phases are combined, washed with saturated sodium bicarbonate solution, then with saturated sodium chloride solution, dried over magnesium sulfate, filtered and concentrated under reduced pressure.
[0068] Application of Procedures A and B to the synthesis of certain monoamides of formula (I) : The various monoamides of formula (I), the synthesis of which is reported below, may have several asymmetric centers which lead to the formation of diastereoisomers. These diastereoisomers are 1 H or 13 C NMR. In addition, each diastereoisomer may have rotamers, which are also visible in NMR. To aid in understanding these NMR analyses, the percentages of each peak have been added below where possible.
[0069] - Synthesis of monoamide EHPip2 : The specific formula: [ka] The monoamide EHPip2 having the formula: was synthesized using procedure B, using 2-ethylhexanoyl chloride (3.00 mL, 17.4 mmol, 1.05 equiv) as the acid chloride, 2-hexylpiperidine hydrochloride (3.40 g, 16.5 mmol, 1.00 equiv) as the cyclic amine salt, triethylamine (5.6 mL, 41.3 mmol, 2.50 equiv), and DCM (165 mL).
[0070] This gave 4.42 g (15.7 mmol) of EHPip2 as a yellow oil. Yield: 95%. 1H NMR (CDCl3, 400 MHz): δ (ppm): 4.92 - 4.83 (m, 1H, 56%), 4.67 - 4.63 (m, 1H, 22%), 4.63 - 4.57 (m, 1H, 22%), 4.07 - 3.97 (m, 1H, 44%), 3.87 - 3.81 (m, 1H, 28%), 3.81 - 3.74 (m, 1H, 28%), 3.07 (t, J = 13. 7 Hz, 1H, 28%), 3.06 (t, J = 13.8 Hz, 1H, 28%), 2.64 - 2.55 (m, 1H, 44% + 1H, 100%), 1.76 - 1.54 (m, 8H), 1.51 - 1.36 (m, 4H), 1.34 - 1.12 (m, 12H), 0.95 - 0.82 (m, 100%) 13 C NMR (CDCl3, 101 MHz): δ (ppm): 174.92 (C=O, 22%), 174.87 (C=O, 22%), 174.6 (C=O, 56%), 53.0 (C=O, 56%), 52.9 (C=O, 44%), 48.1, 48.0, 42.8 (78%), 42.6 (22%), 40.99 (44%), 40.95 (56%), 36.68, 36.66, 33.1, 32.9, 32.6, 32.3, 32.02, 31.98, 31.93, 31.90, 30.63, 30.57, 30.5, 30.2, 30.0, 29.9, 29.6, 29.52, 29.48, 29.45, 29.4, 28.6, 28.5, 26.9, 26.83, 26.76, 26.45, 26.41, 26.39, 26.3, 26.2, 26.00, 25.95, 25.7, 23,2, 23.12, 23.07, 23.06, 22.74, 22.71, 19.35 (44 %), 19.34 (56 %), 14.23, 14.19, 12.7, 12.5, 12.20, 12.16 IR (cm -1 ): 2955, 2924, 2872, 2855, 1636, 1437, 1250, 1217 HRMS (CI+): Theoretical exact mass for C 19 H 38 NO + [M + H] + : 296.2953; experimental: 296.2963.
[0071] - Synthesis of monoamide EHPip3 : The specific formula: [ka] The monoamide EHPip3 having the formula: was synthesized using procedure B, using 2-ethylhexanoyl chloride (890 μL, 5.10 mmol, 1.50 equiv) as the acid chloride, 3-hexylpiperidine hydrochloride (700 mg, 3.40 mmol, 1.00 equiv) as the cyclic amine salt, triethylamine (1.84 mL, 13.6 mmol, 4.00 equiv), and DCM (12 mL).
[0072] This gave 990 mg (3.35 mmol) of EHPip3 as a yellow oil. Yield: 99%. 1 H NMR (CDCl3, 400 MHz): δ (ppm): 4.52 (t, J = 11.8 Hz, 1H, 100%), 3.89 (d, J = 13.2 Hz, 1H, 100%), 2.99 (t, J = 12.3 Hz, 1H, 50%), 2.69 - 2.51 (m, 2H, 100%), 2.32 (q, J = 10.7, 12.3, 1H, 50%), 1.86 (d, J = 12.3 Hz, 1H, 100%), 1.74 - 1.57 (m, 3H, 100%), 1.49 - 1.35 (m, 4H, 100%), 1.33 - 1.05 (m, 15H, 100%), 0.86 (m, 18H, 100%) 13C NMR (CDCl3, 101 MHz): δ (ppm): 174.4 (C=O), 52.10, 52.06, 48.2, 46.7, 42.97, 42.94, 42.65, 42.63, 42.55, 42.52, 37.4, 36.35, 36.31, 34.05, 33.91, 32.81, 32.80, 32.6, 32.5, 31.9, 31.70, 31.68, 31.4, 30.2, 30.1, 30.02, 29.95, 29.7, 29.6, 26.9, 26.8, 26.4, 26.23, 26.19, 26.14, 26.11, 25.4, 23.04, 22.8, 22.7, 14.21, 14.16, 12.44 (50%), 12.42 (50%), 12.3 (50%), 12.2 (50%) IR (cm -1 ): 2957, 2928, 2872, 2855, 1639, 1460, 1439 HRMS (CI+): Theoretical exact mass for C 19 H 38 NO [M + H] + : 296.2953; experimental: 296.2973
[0073] - Synthesis of monoamide PPPip3 : The specific formula: [ka] The monoamide PPPip3 with the formula was synthesized using procedure A, using 2-propylpentanoic acid (2.93 mL, 18.4 mmol, 1.00 equiv.) as the carboxylic acid, 3-hexylpiperidine hydrochloride (3.00 g, 18.4 mmol, 1.00 equiv.) as the cyclic amine salt, HOBt (2.99 g, 22.1 mmol, 1.20 equiv.), DCC (4.56, 22.1, 1.20 equiv.), and 2-methyltetrahydrofuran (184 mL). N,N-Diisopropylethylamine (alternatively DIPEA - 6.6 mL, 36.8 mmol, 2.00 equiv.) was added first to deprotonate 3-hexylpiperidine hydrochloride.
[0074] This gave 4.03 g (13.63 mmol) of PPPip3 as a clear oil. Yield: 74%. 1 H NMR (CDCl3, 400 MHz): δ (ppm): 4.54 (t, J = 12.1 Hz, 1H), 3.91 (d, J = 13.3 Hz, 1H), 2.99 (td, J = 12.7, 2.6 Hz, 1H, 50%), 2.74 - 2.51 (m, 2H), 2, 36 - 2.26 (m, 1H, 50%), 1.91 - 1.83 (m, 1H), 1.73 - 1.58 (m, 3H), 1.45 - 1.17 (m, 19H), 0.95 - 0.83 (m, 9H, -CH3) 13 C NMR (CDCl3, 101 MHz): δ (ppm): 174.6 (C=O), 52.1, 48.2, 46.7, 43.0, 40.6, 40.5, 37.4, 36.3, 35.7, 35.6, 35.5, 34.1, 34.0, 31.9, 31.7, 31.4, 29.7, 29.6, 26.9, 26.8, 26.4, 25.4, 22.79, 22.76, 21.2, 21.1, 21.0, 20.9, 14.42, 14.40, 14.38, 14.2 IR (cm -1 ): 2957, 2922, 2855, 1636, 1441 HRMS (CI+): Theoretical exact mass for C 19 H 38 NO [M + H] + : 296.2953, experimental: 296.2895
[0075] - Synthesis of monoamide EHPip4 : The specific formula: [ka] The monoamide EHPip4 having the formula: was synthesized using procedure B, using 2-ethylhexanoyl chloride (2.48 mL, 14.3 mmol, 1.05 equiv) as the acid chloride, 4-hexylpiperidine hydrochloride (2.80 g, 13.6 mmol, 1.00 equiv) as the cyclic amine salt, triethylamine (4.60 mL, 34.0 mmol, 2.50 equiv), and DCM (136 mL).
[0076] This gave 3.51 g (12.5 mmol) of EHPip4 as a yellow oil. Yield: 92%. 1 H NMR (CDCl3, 400 MHz): δ (ppm): 4.75 - 4.69 (m, 1H, 50%), 4.69 - 4.64 (m, 1H, 50%), 4.07 - 4.01 (m, 1H, 50%), 4.01 - 3.95 (m, 1H, 50%), 2.98 (t, J = 12.4 Hz, 1H, 50%), 2.98 (t, J = 12.4 Hz, 1H, 50%), 2.64 - 2.48 (m, 2H), 1.78 - 1.59 (m, 4H), 1.53 - 1.37 (m, 3H), 1.34 - 1.16 (m, 14H), 1.11 - 0.98 (m, 2H), 0.93 - 0.82 (m, 9H) 13C NMR (CDCl3, 101 MHz): δ (ppm): 173.5 (C=O), 45.2, 41.6, 41.54, 41.45, 41.4, 35.6, 35.4, 32.5, 31.8, 31.6, 31.5, 31.0, 29.1, 29.0, 28.6, 25.7, 25.2, 25.1, 22.1, 22.0, 21.8, 13.24, 13.18, 11.4, 11.2 IR (cm -1 ): 2953, 2926, 2868, 2856, 1628, 1429, 1246 HRMS (CI+): C 19 H 38 Theoretical exact mass of NO [M + H] + : 296.2953, experimental value: 296.2963
[0077] - Synthesis of monoamide EHPyr2 : The specific formula: [ka] The monoamide EHPyr2 having the formula: was synthesized using procedure B, using 2-ethylhexanoyl chloride (2.53 mL, 14.6 mmol, 1.20 equiv) as the acid chloride, 2-heptylpyrrolidine (2.17 g, 12.2 mmol, 1.00 equiv) as the cyclic amine, triethylamine (2.46 mL, 18.3 mmol, 1.50 equiv), and DCM (165 mL).
[0078] This gave 4.42 g (15.7 mmol) of EHPyr2 as a yellow oil. Yield: 82%. 1H NMR (CDCl3, 400 MHz): δ (ppm): 4.17 - 4.08 (m, 1H, 67%), 3.89 - 3.80 (m, 1H, 33%), 3.61 - 3.39 (m, 2H, 100%), 2.42 - 2.31 (m, 1H, 100%), 2.03 - 1.78 (m, 4H), 1.72 - 1.39 (s, 5H), 1.35 - 1.16 (m, 15H), 0.92 - 0.83 (m, 9H) 13 C NMR (CDCl3, 101 MHz): δ (ppm): 175.14 (C=O, 16%), 175.06 (C=O, 16%), 174.73 (C=O, 33%), 174.71 (C=O, 33%), 57.65 (16%), 57.63 (16%), 57.3 (33%), 57.2 (33 %), 47.0 (100 %), 45.73, 45.71, 45.35, 45.32, 45.25, 35.65 (16 %), 35.62 (16 %), 33.48, 33.47, 33.4, 33.0, 32.6, 32.5, 32.0 (67 %), 31.93 (16 %), 31.91 (16 %), 30.5, 30.23, 30.22, 30.19, 29.95, 29.92, 29.74, 29.72, 29.64, 29.56, 29.5, 29.4, 29.3, 29.2, 26.7, 26.7, 26.6, 26.5, 26.0, 25.9, 24.2, 23.2, 23.1, 23.0, 22.8, 22.2, 14.24, 14.21, 14.18, 12.70, 12.41, 12.18, 12.15 IR (cm -1 ): 2957, 2924, 2864, 2855, 2636, 1419 HRMS (CI+): Theoretical exact mass for C 19 H 38 NO [M + H] + : 296.2953, experimental: 296.2962
[0079] II- Extraction characteristics of the monoamides of formula (I) : Extraction tests are performed using: as organic phase: 1.2 mol / L of a solution in TPH of one of the following monoamides: EHPip2, EHPip3, PPPip3, EHPip4 and EHPyr2, and - As aqueous phase: approx. 10 g / L of uranium(VI), approx. 200 kBq / mL of 239~240 An aqueous solution containing plutonium(IV) and nitric acid at a concentration of either 4 mol / L (to simulate the acidity that would likely be exhibited by an aqueous solution produced by dissolving spent nuclear fuel in nitric acid) or 0.5 mol / L (to simulate the acidity that would likely be exhibited by an aqueous solution used to strip plutonium).
[0080] Each of these tests is carried out by contacting one of the organic phases with one of the aqueous phases in a tube with stirring for 30 minutes at 25° C. The O / A volume ratio used is 1. The phases are then separated from each other after centrifugation.
[0081] The uranium(VI) concentration and plutonium(IV) activity in the thus separated organic and aqueous phases are measured by plasma inductively coupled-atomic emission spectrometry (or ICP-AES) and alpha spectrometry, respectively.
[0082] The distribution coefficients of uranium(VI) and plutonium(IV) and the U / Pu separation factor were determined according to the practice in the field of liquid-liquid extraction, i.e. - the distribution coefficient (D) of the metal element M between two phases (organic and aqueous, respectively) M ) is equivalent to:
number
number
[0083] Table I below shows the distribution coefficients (D) of uranium(VI) obtained in the aqueous phase of 4 mol / L HNO3 and 0.5 mol / L HNO3 for each monoamide tested. U ), and the distribution coefficient of plutonium(IV) (D Pu ), and the separation factor U / Pu (FS U / Pu (denoted as "").
[0084] [Table 1]
[0085] For comparison, the table also reports the results of tests carried out under the same operating conditions but using as organic phase: - One of them is a solution containing 1.2 mol / L of MDEHA (N-decyl-N-methyl-2-ethylhexanamide) (see reference [2]) in TPH. MDEHA is an asymmetric monoamide without a cyclic amine and has the same molecular formula (C 19 H 38 NO), which contains a carbonyl group with a 1-ethylpentyl group, similar to the monoamides EHPip2, EHPip3, EHPip4, and EHPyr2; and - The other is a solution containing 1.1 mol / L TBP in TPH, because TBP is the solvent for the PUREX process.
[0086] Table I shows that all monoamides tested co-extract uranium(VI) and plutonium(IV) at high acidity (D>1 at [HNO3]=4 mol / L) and selectively back-extract plutonium(IV) at moderate acidity (D>1 at [HNO3]=0.5 mol / L). Pu <0.05).
[0087] The monoamides of the piperidine ring, EHPip3 and PPPip3, at high acidity ([HNO3] = 4 mol / L), give higher partition coefficients for uranium(VI) and plutonium(IV) than those obtained with MDEHA at the same acidity and at the same concentration in the organic phase, while at moderate acidity they maintain good U / Pu selectivity (FS U / Pu >10).
[0088] However, the most interesting monoamide is the pyrrolidine monoamide EHPyr2. Indeed, this monoamide achieves high U / Pu separation factors at moderate acidity (FS at [HNO3] = 0.5 mol / L) while strongly extracting uranium(VI) and plutonium(IV). U / Pu =33).
[0089] In addition, unlike monoamides such as MDEHA, which extract uranium(VI) more strongly than plutonium(IV), the monoamide EHPyr2 gives similar partition coefficients for uranium(VI) and plutonium(IV) at high acidity ([HNO3]=4 mol / L). These partition coefficients are higher than those obtained at the same acidity and at the same concentration in the organic phase in the case of MDEHA. The U / Pu partition factors obtained at moderate acidity ([HNO3]=0.5 mol / L) are also higher in the case of monoamide EHPyr2 than those obtained with MDEHA at the same acidity.
[0090] It should be noted that the partition coefficients of uranium(VI) and plutonium(IV) obtained at high acidity ([HNO3] = 4 mol / L) for the monoamide EHPyr2 are lower than those obtained at the same acidity for TBP. On the other hand, at moderate acidity ([HNO3] = 0.5 mol / L) the monoamide EHPyr2 gives FS coefficients ten times higher than those obtained at the same acidity for TBP. U / Pu It provides a separation factor and therefore has a much higher U / Pu selectivity than that of TBP.
[0091] III- Uranium(VI)-loading ability of monoamides of formula (I) : The uranium(VI) loading test is carried out by contacting an organic phase containing 1.2 mol / L of the monoamide EHPip3 in TPH five times in succession with an aqueous solution containing 135 g / L of uranium(VI) and 4 mol / L of nitric acid.
[0092] Each contact is carried out in a tube with stirring for 30 minutes at 25°C, with an O / A volume ratio of 2, followed by centrifugation to separate the contacted aqueous and organic phases and measuring the uranium(VI) concentration in the organic phase.
[0093] Table II below shows the uranium(VI) concentrations ([U]) obtained in the organic phase after each of the five contacts. org and expressed in g / L).
[0094] [Table 2]
[0095] In addition to no demixing (i.e., formation of a third phase) being observed during the five contacts, Table II shows that the organic phase containing the monoamide was capable of loading 142 g / L of uranium(VI), representing a high loading capacity compatible with the development of processes for processing spent nuclear fuel.
[0096] IV--Schematic diagram of one embodiment of the processing method of the present invention : Please refer to FIG. 1, which illustrates a schematic diagram of one embodiment of a method for treating an aqueous solution resulting from dissolving spent nuclear fuel in nitric acid, according to the present invention.
[0097] As shown in the figure, the method comprises eight steps.
[0098] The first of these steps, labeled "U / Pu co-extraction" in Figure 1, aims to extract uranium and plutonium together from an aqueous nitric acid solution resulting from the dissolution of spent nuclear fuel, the former in the +VI oxidation state and the latter in the +IV oxidation state.
[0099] Such solutions typically contain 3-6 mol / L HNO3, uranium(VI), plutonium(IV), minor actinides (americium, curium, and neptunium), fission products (La, Ce, Pr, Nd, Sm, Eu, Gd, Mo, Ru, Tc, Rh, Ru, Pd, Y, Cs, Ba, Zr, Nb, ...), and some activation products such as chromium, manganese, iron, cobalt, and nickel.
[0100] The "U / Pu co-extraction" step is carried out by circulating in extractor 1 a solvent in countercurrent to an organic phase (labelled "PO" in Figure 1) comprising 1 mol / L to 2 mol / L, better still 1.1 mol / L to 1.3 mol / L, for example 1.2 mol / L, of the monoamide of formula (I) or a mixture of monoamides in solution in an organic diluent.
[0101] The organic diluent may in particular be a linear or branched hydrocarbon, such as n-dodecane, TPH, or an isoparaffin, such as that commercially available under the trade name Isane™ IP 185T, preferentially TPH.
[0102] The second step of the method, called "PF wash" in FIG. 1, aims to back-extract from the organic phase resulting from the "U / Pu co-extraction" a fraction of the fission and activation products that were extracted from the solution together with uranium(VI) and plutonium(IV).
[0103] To achieve this, the "PF Wash" step comprises one or more washing operations of the organic phase resulting from the "U / Pu co-extraction", each washing operation being carried out by circulating this organic phase in countercurrent to an aqueous nitric acid solution, in an extractor 2, whose concentration can be in the range of 1 mol / L to 6 mol / L HNO3, but preferably 4 mol / L to 6 mol / L HNO3, and even better 4 mol / L to 5 mol / L HNO3, to facilitate back-extraction of ruthenium and technetium.
[0104] If the "PF Wash" step is carried out with one or more strongly acidic aqueous solutions, i.e. typically 3 mol / L or more HNO3, this step also includes deacidifying the organic phase by circulating it countercurrently against a weakly acidic aqueous nitric acid solution, i.e. an aqueous solution containing 0.1 mol / L to 1 mol / L HNO3, for example an aqueous solution containing 0.5 mol / L HNO3, in order not to carry too much acid into the extractor assigned to the third step, labelled "Pu Back Extraction" in FIG. 1, thereby impairing the capacity of this third step.
[0105] This "Pu stripping" step is the first step of the U / Pu partitioning and has the purpose of stripping plutonium in the +IV oxidation state from the organic phase resulting from the "PF wash", thus stripping this plutonium without reducing it.
[0106] It is carried out by circulating this organic phase in an extractor 3 countercurrently to an aqueous solution containing 0.1 mol / L to 0.5 mol / L HNO3, preferably using an O / A flow ratio of more than 1, preferably more than 3 and better still more than 5, so that plutonium(IV) is back-extracted in such a way that it is enriched.
[0107] Stripping of plutonium (IV) carried out in the "Pu stripping" step involves stripping of the uranium (VI) fraction also present in the organic phase resulting from the "PF wash".
[0108] Thus, the fourth step of the method, designated "First U Wash" in FIG. 1 and which is the second step of the U / Pu partition, aims to extract from the aqueous phase resulting from the "Pu back extraction" either: - any uranium(VI) present in this aqueous phase (if the U / Pu partition is desired to result in an aqueous solution containing plutonium(IV) but without uranium(VI) and an organic solution containing uranium(VI) but without plutonium(IV); - or uranium(VI) in an amount making it possible to obtain, at the end of the "first U wash", an aqueous solution containing uranium(VI) and plutonium(IV) in a preselected ratio (if it is desired that the U / Pu partition results in an aqueous solution containing a mixture of plutonium(IV) and uranium(VI) in this ratio, and an organic solution containing uranium(VI) without plutonium(IV)).
[0109] In both cases, the "first U wash" is carried out by circulating in the extractor 4 the aqueous phase resulting from the "Pu back extraction" in countercurrent to an organic phase (noted inter alia as "PO" in FIG. 1) of the same composition as the organic phase used for the "U / Pu co-extraction". The amount of uranium(VI) extracted is adjusted on the one hand by varying the O / A flow ratio and on the other hand by varying the acidity of the aqueous phase; the higher the organic / aqueous flow ratio and the higher the acidity of the aqueous phase, the better the extraction of uranium(VI). Thus, a higher or lower concentration of HNO3 can be added to the aqueous phase circulating in the extractor 4, depending on the acidity that it is desired to bring to this aqueous phase.
[0110] The fifth step, called "α-Tc barrier" in FIG. 1, aims to back-extract from the organic phase resulting from "back-extracted Pu" the technetium part (fraction) that was extracted in "co-extracted U / Pu" and not back-extracted during "PF wash", in order to enhance the decontamination of this organic phase with respect to technetium.
[0111] It also makes it possible to back-extract from the organic phase resulting from "Pu back-extraction" the fraction of neptunium extracted during "U / Pu co-extraction" and the fraction of neptunium following technetium up to the "α-Tc barrier", as well as any traces of plutonium(IV) that this organic phase may still contain.
[0112] It is carried out by circulating in an extractor 5 the organic phase resulting from the "Pu back extraction" in countercurrent to an aqueous nitric acid solution containing 0.1 mol / L to 3 mol / L HNO3, better still 1 mol / L HNO3, and one or more reducing agents for reducing technetium (present in the organic phase in the +VII oxidation state) to technetium(IV), neptunium(VI) to neptunium(IV) or neptunium(V) and plutonium(IV) to plutonium(III), respectively, without reducing uranium(VI). In the case of this type of acidity, technetium(IV) and neptunium(IV) are not extractable by the monoamide of formula (I), while plutonium(III) is less extractable than plutonium(IV).
[0113] As reducing agents, uranyl nitrate (or U(IV)), hydrazinium nitrate (or NH), hydroxylammonium nitrate (or NHA), and acetaldoxime, hydroxyiminoalkanoic acids (for example 6-hydroxyiminohexanoic acid), or mixtures thereof, for example U(IV) / NH, U(IV) / NHA, or U(IV) / acetaldoxime mixtures, preferentially U(IV) / NH or U(VI) / NHA mixtures, can be used in this way. If necessary, gluconic acid can be added to the aqueous solution to reduce the phenomenon of reoxidation of technetium(IV) in the aqueous phase, thereby limiting the consumption of the reducing agent(s).
[0114] This step can be carried out at room temperature (i.e. 20-25°C), but is preferably carried out at a temperature between 30°C and 40°C, better still at 32°C, so as to promote the stripping rate of technetium(IV) while limiting the reoxidation phenomenon of technetium(IV) in the aqueous phase, and thus limiting the risk of technetium once stripped being re-extracted into the organic phase.
[0115] The sixth step, labeled "Second U Wash" in Figure 1, is intended to extract the uranium(VI) that was back-extracted together with technetium in the previous step from the aqueous phase resulting from the "α-Tc barrier", in order to prevent the "α-Tc barrier" step from resulting in too large a loss of uranium(VI) into the aqueous phase.
[0116] It is carried out by circulating in the extractor 6 the aqueous phase resulting from the "α-Tc barrier" in countercurrent to an organic phase (also designated "PO" in FIG. 1) having the same composition as the organic phase used for the "U / Pu co-extraction" and the "first U wash", after acidifying this aqueous phase by adding concentrated nitric acid, in particular 10 mol / L concentrated nitric acid, to promote the extraction of uranium(VI).
[0117] The seventh step, labeled “U back-extraction” in Figure 1, aims to back-extract uranium(VI) from the organic phase resulting from the “α-Tc barrier”.
[0118] It is carried out by circulating in an extractor 7 the organic phase emerging from the "α-Tc barrier" in countercurrent against an aqueous nitric acid solution containing at most 0.5 mol / L, better still at most 0.05 mol / L HNO3, for example an aqueous solution containing 0.01 mol / L HNO3. This step can be carried out at room temperature (for example at 20-25°C), but is preferably carried out under heating (i.e. at a temperature typically between 40 and 50°C) and using an O / A flow ratio greater than 1, so that uranium(VI) is extracted in a concentrated manner.
[0119] At the end of these seven steps you will have: - two raffinates, which correspond to the aqueous phases leaving the extractors 1 and 6, respectively, containing, for the first one, fission and activation products as well as americium and curium ("primary raffinate" in FIG. 1), and for the second one, technetium, neptunium and possibly traces of plutonium ("secondary raffinate" in FIG. 1; - an aqueous phase leaving the extractor 4, which contains either decontaminated plutonium(IV) or a mixture of decontaminated plutonium(IV) and uranium(VI), called "Pu stream" or "Pu+U stream" as appropriate; - an aqueous phase leaving the extractor 7, which contains the decontaminated uranium(VI) and is called the "U stream"; and an organic phase leaving extractor 7, which no longer contains either plutonium(IV) or uranium(VI), but may contain some impurities which may have accumulated during the previous steps and decomposition products of the extractant (formed by hydrolysis and radiolysis);
[0120] The eighth step, labeled "PO Wash" in Fig. 1, therefore aims to regenerate this organic phase by subjecting it to one or more washes with aqueous basic solutions, for example a first wash with 0.3 mol / L aqueous sodium carbonate, followed by a second wash with 0.1 mol / L sodium hydroxide, followed by one or more washes with aqueous nitric acid for reacidification, for example an aqueous solution containing 2 mol / L HNO3, each wash being carried out by circulating said organic phase in an extractor in countercurrent to the aqueous washes.
[0121] As seen in FIG. 1, the organic phase thus regenerated can then be returned to extractors 1 and 4 for reintroduction into the treatment cycle.
[0122] (References) [1] International Publication No. 2017 / 017207 [2] International Publication No. 2017 / 017193 [3] International Publication No. 2018 / 138441 [4] International Publication No. 2019 / 002788 [5]TH Siddall, Journal of Physical Chemistry 1960, 64, 12, 1863-1866 [6] H. Jing-Tian et al., Journal of Radioanalytical and Nuclear Chemistry 1999, 241, 215-217 [Explanation of symbols]
[0123] 1...U / Pu co-extraction 2. PF cleaning 3...Pu back extraction 4. First U-cleaning 5. α-Tc barrier 6. Second U-cleaning 7...U back extraction
Claims
1. Use of the following formula (I) for extracting uranium (VI) and / or plutonium (IV) from an acidic aqueous solution having a pH less than 0: 【Chemistry 1】 (wherein, n = 1, 2, or 3; R 1 is a straight or branched chain alkyl group containing 4 to 12 carbon atoms; and R 2 is a straight or branched chain alkyl or alkoxy group, the chain of which may optionally be interrupted one or more times by oxygen atoms, the total number of carbon atoms and, where applicable, oxygen atoms being between 3 and 10. of a monoamide or a mixture of a plurality of monoamides.
2. The use according to claim 1, comprising contacting the acidic aqueous solution with an organic solution containing a monoamide or a mixture of a plurality of monoamides in an organic diluent, and then separating the aqueous solution and the organic solution from each other.
3. The use according to claim 2, wherein the organic solution contains a monoamide or a mixture of a plurality of monoamides at 1 mol / L to 2 mol / L, preferably 1.1 mol / L to 1.3 mol / L.
4. The use according to any one of claims 1 to 3, wherein the acidic aqueous solution having a pH less than 0 is an aqueous solution produced by dissolving used nuclear fuel in nitric acid.
5. Use of the following formula (I) for completely or partially separating uranium (VI) from plutonium (IV) from an acidic aqueous solution having a pH less than 0: 【Chemistry 2】 (wherein, n = 1, 2, or 3, R 1 is a linear or branched alkyl group containing 4 to 12 carbon atoms, R 2 is a straight or branched chain alkyl or alkoxy group, the chain of which may optionally be interrupted one or more times by oxygen atoms, the total number of carbon atoms and, where applicable, oxygen atoms being between 3 and 10. of a monoamide or a mixture of a plurality of monoamides, comprising the following steps: a) A step of co-extracting uranium (VI) and plutonium (IV) from the aqueous solution, comprising contacting the aqueous solution with an organic solution S1 containing a monoamide or a mixture of a plurality of monoamides in an organic diluent at least once, and then separating the aqueous solution and the organic solution from each other; b) A step of back-extracting plutonium in the +IV oxidation state and a part (fraction) of uranium (VI) from the organic solution resulting from step a), comprising contacting the organic solution with an acidic aqueous solution having a pH greater than 0 at least once, and then separating the organic solution and the aqueous solution from each other; and c) A step of re-extracting all or part of the uranium (VI) fraction present in the aqueous solution resulting from step b), comprising contacting the aqueous solution with an organic solution S2 containing a monoamide or a mixture of a plurality of monoamides in an organic diluent at least once, and then separating the aqueous solution and the organic solution from each other. Including, Thereby, an aqueous solution containing plutonium (IV) without containing uranium (VI) or a mixture of plutonium (IV) and uranium (VI), and an organic solution containing uranium (VI) without containing plutonium (IV) are obtained. Use.
6. 6. Use according to claim 5, wherein the organic solutions S1 and S2 comprise a monoamide or a mixture of monoamides in a concentration of from 1 mol / L to 2 mol / L, preferably from 1.1 mol / L to 1.3 mol / L.
7. 7. The use according to claim 5 or 6, wherein the acidic aqueous solution having a pH of less than 0 is an aqueous solution resulting from dissolving spent nuclear fuel in nitric acid, while the acidic aqueous solution having a pH of greater than 0 is a solution containing 0.1 mol / L to 0.5 mol / L of nitric acid.
8. 8. The use according to any one of claims 1 to 7, wherein n=2 or 3.
9. R 1 is a linear or branched alkyl group, preferably a branched alkyl group, containing from 6 to 10 carbon atoms; and / or R 2 is a linear or branched alkyl group containing 4 to 10 carbon atoms, preferably a linear alkyl group; 9. Use according to any one of claims 1 to 8.
10. The monoamide is N-(2-heptylpyrrolidinyl)-(2-ethyl)hexanamide, N-(2-hexylpiperidinyl)-(2-ethyl)hexanamide, N-(3-hexylpiperidinyl)-(2-ethyl)hexanamide, N-(4-hexylpiperidinyl)-(2-ethyl)hexanamide, or N-(3-hexylpiperidinyl)-(2-propyl)pentanamide 10. The use according to any one of claims 1 to 9, wherein
11. A method for treating in a cycle an aqueous solution resulting from dissolving spent nuclear fuel in nitric acid, said aqueous solution containing fission and activation products including uranium (VI), plutonium (IV), americium (III), curium (III), and ruthenium and technetium, said cycle comprising the steps of: a) co-extraction of uranium (VI) and plutonium (IV) from said aqueous solution, comprising contacting said aqueous solution at least once in an extractor with an organic solution S1 comprising a monoamide or a mixture of monoamides in an organic diluent, followed by separation of the aqueous and organic solutions from each other, said monoamide or monoamides being represented by the formula (I) below: 【Chemistry 3】 (In the formula, n=1, 2, or 3; R 1 is a straight or branched chain alkyl group containing 4 to 12 carbon atoms; and R 2 is a straight or branched chain alkyl or alkoxy group, the chain of which may optionally be interrupted one or more times by oxygen atoms, the total number of carbon atoms and, where applicable, oxygen atoms being between 3 and 10. a co-extraction step represented by: b) decontaminating the organic solution resulting from step a) with respect to americium (III), curium (III) and fission and activation products, comprising contacting said organic solution at least once in an extractor with an aqueous solution containing 0.5 mol / L to 6 mol / L nitric acid, followed by separating the organic and aqueous solutions from each other; c) partitioning the uranium(VI) and plutonium(IV) present in the organic solution resulting from step b) between an aqueous solution containing plutonium(IV) but not uranium(VI) or a mixture of plutonium(IV) and uranium(VI) and an organic solution containing uranium(VI) but not plutonium(IV), the partitioning comprising the following steps: c 1 a step of back-extracting plutonium (IV) + IV oxidation state and a fraction of uranium (VI) from the organic solution resulting from step b), comprising contacting the organic solution at least once in an extractor with an aqueous solution containing 0.1 mol / L to 0.5 mol / L nitric acid, followed by separating the organic and aqueous solutions from each other; c 2 ) process c 1 re-extracting all or part of the uranium(VI) fraction present in the aqueous solution resulting from the extraction of uranium(VI) from the aqueous solution S2, which comprises contacting said aqueous solution at least once in an extractor with an organic solution S2 comprising a monoamide or a mixture of monoamides in an organic diluent, followed by separating the organic and aqueous solutions from each other; a dispensing step comprising: d) Process c 1 ) with respect to technetium, the decontamination comprising the steps of: d 1 ) process c 1 back-extracting technetium in the +IV oxidation state from an organic solution resulting from the extraction of technetium in the +VII oxidation state, comprising contacting the organic solution at least once in an extractor with an aqueous solution containing 0.1 mol / L to 3 mol / L of nitric acid and at least one reducing agent capable of reducing technetium in the +VII oxidation state to the +IV oxidation state, followed by separating the organic and aqueous solutions from each other; d 2 ) process d 1 re-extracting the uranium(VI) fraction present in the aqueous solution resulting from the extraction of uranium(VI) from the aqueous solution S2, which comprises contacting said aqueous solution at least once in an extractor with an organic solution S3 comprising a monoamide or a mixture of monoamides in an organic diluent, followed by separating the organic and aqueous solutions from each other; a decontamination step comprising: e) Process d 1 stripping uranium(VI) from an organic solution resulting from the extraction of uranium(VI) from the uranium(VI)-containing uranium-containing nitrate, comprising contacting the organic solution with an aqueous solution containing at most 0.05 mol / L of nitric acid in an extractor at least once, followed by separating the organic and aqueous solutions from each other; and f) optionally regenerating the organic solution resulting from step e); Including, Thereby, first and second aqueous solutions decontaminated with respect to americium (III), curium (III) and fission and activation products are obtained, the first aqueous solution containing plutonium (IV) without uranium (VI) or a mixture of plutonium (IV) and uranium (VI), and the second aqueous solution containing uranium (VI) without plutonium (IV), method.
12. 12. The method according to claim 11, wherein the organic solutions S1, S2 and S3 contain from 1 mol / L to 2 mol / L, preferably from 1.1 mol / L to 1.3 mol / L, of a monoamide or a mixture of monoamides.
13. The method according to claim 11 or 12, wherein the aqueous solution of step b) contains 4 mol / L to 6 mol / L of nitric acid.
14. Process c 1 14. The method of any one of claims 11 to 13, wherein contacting the organic solution and the aqueous solution in an extractor of at least one of said extractors comprises circulating the organic solution and the aqueous solution at a flow rate ratio of the organic solution to the aqueous solution of greater than 1, preferably 3 or more.
15. 15. The method according to any one of claims 11 to 14, wherein the reducing agent is uranyl nitrate, hydrazinium nitrate, hydroxylammonium nitrate, acetaldoxime, hydroxyiminoalkanoic acid, or a mixture thereof, preferably a mixture of uranyl nitrate and hydrazinium nitrate, or a mixture of uranyl nitrate and hydroxylammonium nitrate.
16. - Step D 1 ) is heated to a temperature of 30°C to 40°C, and / or - the extractor of step e) is heated to a temperature between 40°C and 50°C; 16. The method according to any one of claims 11 to 15.
17. 17. The method of any one of claims 11 to 16, wherein contacting the organic solution and the aqueous solution in the extractor of step e) comprises circulating the organic solution and the aqueous solution at a flow ratio of the organic solution to the aqueous solution greater than 1.
18. 18. The method according to any one of claims 11 to 17, wherein the organic solution resulting from step e) is regenerated and then separated into a first and a second portion, the first portion forming organic solution S1 and the second portion forming organic solution S2.
19. 19. The method of any one of claims 11 to 18, wherein n=2 or 3.
20. R 1 is a linear or branched alkyl group, preferably a branched alkyl group, containing from 6 to 10 carbon atoms; and / or R 2 is a linear or branched alkyl group containing 4 to 10 carbon atoms, preferably a linear alkyl group; 20. The method according to any one of claims 11 to 19.
21. The monoamide is N-(2-heptylpyrrolidinyl)-(2-ethyl)hexanamide, N-(2-hexylpiperidinyl)-(2-ethyl)hexanamide, N-(3-hexylpiperidinyl)-(2-ethyl)hexanamide, N-(4-hexylpiperidinyl)-(2-ethyl)hexanamide, or N-(3-hexylpiperidinyl)-(2-propyl)pentanamide 21. The method according to any one of claims 11 to 20, wherein
22. N-(2-heptylpyrrolidinyl)-(2-ethyl)hexanamide, N-(2-hexylpiperidinyl)-(2-ethyl)hexanamide, N-(3-hexylpiperidinyl)-(2-ethyl)hexanamide, N-(4-hexylpiperidinyl)-(2-ethyl)hexanamide, or N-(3-hexylpiperidinyl)-(2-propyl)pentanamide , a monoamide.
Citation Information
Patent Citations
Multi-functionalization bis(butanediamide) compounds and preparation and use thereof
CN105777570A
Method of separating u and pu present in aqueous solution by cyclic amide compound
JP1999064579A
Method for separating plutonium into water phase by utilizing difference of nitric acid concentration from uranium and plutonium recovered in organic phase including branched n,n-dialkyl amide
JP2007240370A
A method for the treatment of aqueous nitric acid solutions resulting from dissolution of spent nuclear fuel in a single cycle and without any operation involving reductive back-extraction of plutonium
JP2018527561A
Novel unsymmetrical n,n-dialkylamides, their synthesis and use
JP2018532691A
